Open original FDA record ↗Recall record
- FDA identifier
- Z-1316-2012
- Company in FDA record
- Ortho-Clinical Diagnostics
- FDA classification date
- Mar 26, 2012
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 17, 2026
- Recall classification
- Unknown — no matched enforcement classification
Reason stated in the source
Ortho Clinical Diagnostics (OCD) has revised the VITROS dHDL Slides Instructions for Use (IFU) and removed EDTA plasma as a recommended sample type.
Source facts
- Action
- Ortho Clinical Diagnostics sent an Important Product Information letter dated February 2, 2012, to all affected customers via Federal Express overnight mail. The letter informed customers of the issue, notifying them of the removal of EDTA plasma as a recommended sample type and providing the revised VITROS dHDL Slides Instructions for Use. J&J Foreign affiliate consignees were notified by email informing them of the issue on 02 February 2012. Customers were instructed to replace the current pages in their VITROS Chemistry Products Instructions for Use Manual with the updated instructions for Use and Table of Contents. Customers were asked to return the enclosed Confirmation of Receipt form regardless of whether their laboratory uses the affected product. For any questions regarding this recall call 1-800-421-3311.
- Initiated
- 2012-02-02
- Root cause
- Device Design
- Terminated
- 2018-07-05
- Distribution
- Worldwide Distribution
- Recall number
- Z-1316-2012
- Recall status
- Terminated
- CDRH record ID
- 107602
- FDA classified
- 2012-03-26
- Recall event number
- 61222